BioDelivery Sciences International, Inc. (BDSI) Research

BioDelivery Sciences International, Inc. (BDSI) is a specialized pharmaceutical firm dedicated to the advancement and commercialization of therapeutic products designed for long-term health conditions, serving markets both within the United States and internationally. The company's product offerings leverage its proprietary BioErodible MucoAdhesive drug delivery system—a slender, dissolving polymer film intended for application to the inner cheek—in addition to other drug administration methodologies. Its portfolio includes several key products: BELBUCA, a buprenorphine buccal film, is utilized for the ongoing management of persistent pain. Symproic functions as a peripherally acting mu-opioid receptor antagonist, specifically addressing opioid-induced constipation in adult patients suffering from chronic non-cancer pain. This also covers individuals whose chronic pain is a result of prior cancer or its treatment, provided they do not require frequent increases in opioid dosage. ELYXYB, an oral solution containing celecoxib, provides treatment for adult migraines, irrespective of the presence of an aura. ONSOLIS, a soluble fentanyl film administered buccally, is intended for the management of sudden, severe "breakthrough" pain experienced by cancer patients. Founded in 1997, BioDelivery Sciences International, Inc. is headquartered in Raleigh, North Carolina. As of March 18, 2022, the company operates as a subsidiary of Collegium Pharmaceutical, Inc.

Market snapshot

Symbol
BDSI
Price
$5.59
Day change
-0.09%
Market cap
$577.1M
P/E ratio
6.80x
52-week range
2.5-5.62
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Peer companies

  • Accolade, Inc. (ACCD)
  • Alimera Sciences, Inc. (ALIM)
  • Apollo Endosurgery, Inc. (APEN)
  • Exscientia plc (EXAI)
  • GRAIL, Inc. Common Stock (GRALV)
  • Invivyd, Inc. (IVVD)
  • Regulus Therapeutics Inc. (RGLS)
  • Sage Therapeutics, Inc. (SAGE)

Recent insider activity

  • Watson W. Mark — D-Return (54740 shares) on 2022-03-22
  • Watson W. Mark — J-Other (90663 shares) on 2022-03-22
  • Vollins James — D-Return (282055 shares) on 2022-03-22
  • Vollins James — D-Return (269244 shares) on 2022-03-22
  • Vollins James — D-Return (43334 shares) on 2022-03-22

Open BioDelivery Sciences International, Inc. (BDSI) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.